Andrew Noble

Andrew Noble is a seasoned medical communications professional with 30 years of experience, currently serving as the Director of Medical Writing Excellence at Bioscript. Having worked across Europe, Japan, and with US-based clients, Andrew specializes in the oncology market and has dedicated over 20 years to developing high-quality content and providing strategic direction for pre- and post-launch strategies of novel anticancer agents. Previously, Andrew held various roles, including Editorial Quality and Compliance Director at Bioscript and Medical Writer at Gardiner-Caldwell Communications, where they focused on mentoring and developing medical writers. Andrew's commitment to excellence is complemented by academic credentials in genetics from the University of Newcastle-upon-Tyne.